Search results
Start date:
May 09, 2026
End date:
May 12, 2026
ESC Heart Failure Congress 2026 (Heart Failure 2026), organised by the Heart Failure Association of the European Society of Cardiology (ESC), will take place from 9–12 May 2026 in Barcelona, Spain. Under the theme “Evolution in Heart Failure”, the congress focuses on transforming discovery into impact, advancing prevention, precision diagnosis and treatment of heart failure worldwide.Who should…
View more
Author(s):
Ruth Masterson Creber
Added:
1 year ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different…
View more
THT 2026
Start date:
Mar 02, 2026
End date:
Mar 04, 2026
Event
Author(s):
Archana Ganapathy
,
Jason N Dungu
,
Anthony D Dimarco
,
et al
Added:
1 month ago
Added:
1 year ago
Source:
Heart Failure 2024
Heart Failure Congress 2024 has unveiled 8 Late-breaking trial sessions for 2024.Heart Failure 2024 will take place at the Lisbon Congress Center in May. Access the full Programme here.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators, and keep up to date with our Late-Breaker Discussions with Dr Van Spall.Late…
View more
Device Therapies in Heart Failure
Author(s):
Yoel Benarroch
,
Natalie Tapaskar
,
Amin Yehya
Added:
6 months ago
Review Article
Added:
1 month ago
In this episode of Parallax, Dr Ankur Kalra welcomes Dr Rakesh Shah, a former interventional cardiologist, Oxford MBA graduate, and founder of DRS.LINQ. Dr Shah brings a unique perspective on addressing critical delays in heart attack diagnosis through the intersection of clinical medicine, engineering, and business strategy.The conversation explores a pressing challenge in cardiovascular care:…
View more
Author(s):
Josip A Borovac
,
Dino Miric
Added:
3 months ago
Author(s):
Karol Mirkowski
,
Ercole Vellone
,
Bernadetta Żółkowska
,
et al
Added:
1 year ago
Author(s):
Ahmad Masri
Added:
6 months ago
HFSA 25 - Aficamten found to significantly improve NYHA and KCCQ-CSS scores in new 96-week data from FOREST-HCM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss findings from the FOREST-HCM trial, examining the sustained safety and efficacy of aficamten in patients with symptomatic nonobstructive hypertrophic cardiomyopathy.This phase 2 open-label study followed 34…
View more